Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMountview Est. Regulatory News (MTVW)

Share Price Information for Mountview Est. (MTVW)

Share Price is delayed by 15 minutes
Get Live Data
9,000.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 200.00 (2.273%)
Market Cap: £350.91m
MTVW Live PriceLast checked at - London Stock Exchange

Intraday Mountview Est. Share Chart

Interim Results

26 Nov 2009 07:00

RNS Number : 0959D
Mountview Estates PLC
26 November 2009
 



CHAIRMAN'S STATEMENT

On the following pages are the unaudited Accounts for the six months ended 30 September 2009. At this time last year house prices had fallen significantly and since then we have been through turbulent times. 

At present house prices have recovered to some extent and now stand at similar levels to this time last year. This recovery has been stimulated by a combination of artificially low interest rates, a reduction in stamp duty and value added tax, quantitative easing and the excess of demand over supply. 

Stamp duty and value added tax are due to return to their previous higher levels and quantitative easing may lead to a rise in the rate of inflation which has to be contained by an increase in base rate. Nevertheless we believe it is reasonable to expect the housing market to remain buoyant until the General Election. Thereafter, whatever the complexion of the government then gaining power, it is widely accepted that there will be both cuts in government spending and increases in taxation. 

Against this background it is pleasing to report profits for the six months which almost match those for the whole of the previous financial year and with the prospect of further profitable trading during the second six months. Compared with the same period last year revenue is down by 12% but cost of sales is down by over 40% thus giving a rise in gross profit of 25%. Administrative expenses have barely risen and net finance costs are down by 55% thus giving an increase in net profit of 68%. 

Long-term borrowings have been reduced by £12 million during the period under review and we continue to place an emphasis on the repayment of debt. We have been able to extend the Group's long-term borrowing facilities of £95 million until 2014 and we aim to be in a strong position when the best purchasing opportunities are identified. 

There may be further difficult times ahead but the company is in a strong financial position and getting stronger still. The interim dividend is maintained at 50 pence per share and will be payable on 29 March 2010 to shareholders on the register at 26 February 2010.

GROUP INCOME STATEMENT (UNAUDITED)

Half year 

Half year

Year

ended

ended

ended

30.09.2009

30.09.2008

31.03.2009

£000

£000

£000

Revenue

25,274

28,578

53,599

Cost of Sales

(9,382)

(15,910)

(27,657)

Gross Profit 

15,892

12,668

25,942

Administrative expenses

(1,487)

(1,477)

(3,767)

Operating profit before changes in

fair value of investment properties

14,405

11,191

22,175

(Decrease) in fair value of investments

-

-

(3,210)

Profit from operations

14,405

11,191

18,965

Net finance costs

(1,560)

(3,444)

(5,903)

Profit before taxation

12,845

7,747

13,062

Taxation - current 

(3,700)

(2,325)

(4,864)

Taxation - deferred

112

79

1,191

Taxation

(3,588)

(2,246)

(3,673)

Profit attributable to equity shareholders

9,257

5,501

9,389

Basic and diluted earnings per share (pence)

237.4

141.1p

241.0

All items within the consolidated income statement relate to continuing operations.

GROUP BALANCE SHEET (UNAUDITED)

As at 

As at

As at

30.09.2009

30.09.2008

31.03.2009

£000

£000

£000

Assets

Non-current assets

Property plant and equipment

2,499

2,652

2,567

Investment properties

31,916

36,386

32,195

34,415

39,038

34,762

Current assets

Inventories of trading properties

263,254

275,752

268,806

Trade and other receivables

881

1,412

660

Cash and cash equivalents

238

269

840

264,373

277,433

270,306

Total assets

298,788

316,471

305,068

Equity and liabilities 

Capital and reserves attributable 

to equity holders of the company

Share capital

195

195

195

Capital redemption reserve

55

55

55

Capital reserve

25

25

25

Other reserve

56

56

56

Cash flow hedge reserve

(3,119)

-

(3,614)

Retained earnings

195,937

188,834

190,773

193,149

189,165

187,490

Non-current liabilities

Long-term borrowings

76,000

95,000

88,000

Deferred tax

8,394

9,618

8,506

84,394

104,618

96,506

Current liabilities

Bank overdrafts and loans

13,906

19,288

13,026

Trade and other payables

502

1,075

2,055

Current tax payable

3,718

2,325

2,377

Derivative financial instruments 

3,119

-

3,614

21,245

22,688

21,072

Total liabilities

105,639

127,306

117,578

Total equity and liabilities

298,788

316,471

305,068

GROUP CASHFLOW STATEMENT (UNAUDITED)

Half year 

Half year 

Year

ended

ended

ended

30.09.2009

30.09.2008

31.03.2009

£000

£000

£000

Cash flows from operating activities

Profit from operations

14,405

11,191

18,965

Adjustment for:

Depreciation

76

100

192

Loss on disposal of property, plant and equipment

-

2

145

Decrease in fair value of investment properties 

-

-

3,210

Cash flow from operations before movement

in working capital

14,481

11,293

22,512

Decrease/(Increase) in inventories

5,552

(4,391)

2,555

(Increase)/Decrease in receivables

(221)

(294)

459

(Decrease) in payables 

(1,556)

(2,005)

(1,053)

Cash generated from operations

18,256

4,603

24,473

Interest paid

(1,564)

(3,446)

(5,906)

Income taxes paid

(2,356)

(3,985)

(6,443)

Net cash inflow/(outflow) from operating activities

14,336

(2,828)

12,124

Investing activities

Interest received

-

2

3

Proceeds from disposal of investment properties

650

-

1,005

Proceeds from disposal of property, plant and equipment

-

15

15

Purchase of property, plant and equipment

(7)

(48)

(58)

Capital expenditure on investment properties

(371)

(183)

(350)

Net cash inflow/(outflow) from investing activities

272

(214)

615

Cash flows from financing activities 

Increase in borrowings

-

390

-

Repayment of borrowings

(12,700)

-

(9,110)

Equity dividend paid

(4,093)

(4,093)

(6,042)

Net cash (outflow) from financing activities 

(16,793)

(3,703)

(15,152)

Net (decrease) in cash and cash equivalents

(2,185)

(6,745)

(2,413)

Opening cash and cash equivalents

(11,211)

(8,798)

(8,798)

Closing cash and cash equivalents

(13,396)

(15,543)

(11,211)

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Half year

Half year

Year

ended

ended

ended

30.09.2009

30.09.2008

31.03.2009

£000

£000

£000

Shareholders' funds as at 1 April 

187,490

187,757

187,757

Profit for the period

9,257

5,501

9,389

Change in fair value of cash flow hedge

495

-

(3,614)

Dividends

(4,093)

(4,093)

(6,042)

Shareholders' funds at the end of the period

193,149

189,165

187,490 

CONSOLIDATED STATEMENT OF RECOGNISED INCOME AND EXPENSE

Half year

Half year

Year

ended

ended

ended

30.09.2009

30.09.2008

31.03.2009

£000

£000

£000

Profit for the year  

9,257

5,501

9,389

Change in fair value of cash flow hedge

495

-

(3,614)

Total recognised income

9,752

5,501

5,775

The total recognised income 

in the year is attributable to: 

Equity shareholders of the parent

9,752

5,501

5,775 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR FEIFMISUSELF
Date   Source Headline
26th May 202610:27 amRNSUpdate on General Meeting voting outcome
20th Apr 202611:00 amRNSHolding(s) in Company
20th Apr 202610:59 amRNSHolding(s) in Company
20th Apr 202610:58 amRNSHolding(s) in Company
31st Mar 202611:05 amRNSDirector/PDMR Shareholding
30th Mar 20266:30 pmRNSDividend Payment Delay
25th Mar 20265:04 pmRNSDirector/PDMR Shareholding
25th Mar 202610:01 amRNSDirector/PDMR Shareholding
19th Mar 202610:02 amRNSDirector/PDMR Shareholding
18th Mar 202612:29 pmRNSDirector/PDMR Shareholding
25th Feb 20264:21 pmRNSDirector/PDMR Shareholding
23rd Feb 202612:49 pmRNSDirector/PDMR Shareholding
12th Feb 202612:03 pmRNSDirector/PDMR Shareholding
10th Feb 20264:28 pmRNSDirector/PDMR Shareholding
9th Feb 202611:16 amRNSDirector/PDMR Shareholding
26th Jan 20263:38 pmRNSBoard Committee change
22nd Dec 202511:40 amRNSDirector/PDMR Shareholding
22nd Dec 202511:40 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSUnaudited Interim Results for 6m ended 30 Sep 2025
17th Nov 202512:15 pmRNSResult of General Meeting
22nd Oct 202512:00 pmRNSNotice of General Meeting
17th Oct 202512:22 pmRNSDirector/PDMR Shareholding
16th Oct 20251:04 pmRNSDirector/PDMR Shareholding
15th Oct 20254:29 pmRNSDirector/PDMR Shareholding
1st Oct 20251:16 pmRNSDirector/PDMR Shareholding
15th Aug 20257:03 amRNSBoard changes
13th Aug 20251:46 pmRNSResult of Annual General Meeting
30th Jul 20255:10 pmRNS2025 Annual Report and Accounts
24th Jul 202512:32 pmRNSDirector/PDMR Shareholding
22nd Jul 20251:05 pmRNSDirector/PDMR Shareholding
17th Jul 20255:20 pmRNSDirector/PDMR Shareholding
11th Jul 202511:22 amRNSPublication of 2025 Annual Report & Notice of AGM
19th Jun 20257:00 amRNSPreliminary Results: year ended 31 March 2025
16th May 20257:00 amRNSUpdate on General Meeting voting outcome
31st Mar 20257:00 amRNSDirectorate change – Contract Extension
26th Mar 202512:02 pmRNSDirector/PDMR Shareholdings
28th Feb 20255:25 pmRNSDirector/PDMR Shareholding
14th Feb 20257:00 amRNSUpdate on 2024 Annual General Meeting outcome
21st Nov 20242:09 pmRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSUnaudited Interim Results for 6m ended 30 Sep 2024
19th Nov 20249:59 amRNSDirectorate Change
18th Nov 202412:07 pmRNSResult of General Meeting
23rd Oct 202412:00 pmRNSNotice of General Meeting
19th Sep 20246:11 pmRNSDirector/PDMR Shareholding
14th Aug 20241:37 pmRNSResult of Annual General Meeting
23rd Jul 20248:58 amRNSPublication of 2024 Annual Report and Accounts
12th Jul 20249:31 amRNSAnnual Financial Report and Notice of AGM
20th Jun 20247:00 amRNSPreliminary Results: year ended 31 March 2024
20th May 20247:00 amRNSUpdate on General Meeting voting outcome
14th Mar 20242:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.